EAGLE PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$1.01M, a 87.5% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was -$11.8M, a 32% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$19.5M, a 167% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.32M, a 28.8% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$10.3M, a 5716% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$11.8M -$1.01M +$7.07M +87.5% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 -$18.9M -$1.54M +$627K +28.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$19.5M $3.84M +$8.51M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 -$28M -$13.1M -$10.6M -429% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$17.4M -$8.07M -$2.8M -53.1% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 -$14.6M -$2.17M -$7.28M -142% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$7.32M -$4.68M -$6.27M -393% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$1.05M -$2.48M +$4.01M +61.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$5.06M -$5.27M -$6.94M -417% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.88M $5.11M +$12.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$10.3M $1.59M +$1.13M +246% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$11.4M -$6.49M -$6.43M -11093% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$4.98M $1.66M +$1.69M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$6.67M -$7.04M -$6.85M -3568% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $183K $461K +$957K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 -$774K -$58K +$676K +92.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$1.45M -$28K +$672K +96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$2.12M -$192K +$456K +70.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$2.58M -$496K +$7K +1.39% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 -$2.59M -$734K -$242K -49.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$2.34M -$700K -$674K -2592% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$1.67M -$648K -$624K -2600% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$1.05M -$503K -$509K -8483% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$536K -$492K -$515K -2239% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$21K -$26K -$53K -196% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $32K -$24K -$44K -220% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $76K $6K +$6K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $70K $23K +$20K +667% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $50K $27K +$22K +440% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $28K $20K +$14K +233% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $14K $0 $0 Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $14K $3K +$1K +50% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $13K $5K -$43K -89.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $56K $6K +$382K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$326K $0 +$190K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$516K $2K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $48K +$553K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$376K +$122K +24.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$190K Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q2 2013 -$505K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$498K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.